Flaum Eye Institute / Research / Labs / Feldon Lab / Publications

Recent Publications from Feldon Lab

1. Mazzoli RA
2. Seiff SR
3. Bartley GB
4. McLeod SD
5. Feldon SE
6. Nathens A
7. Fountain TR
8. Rapuano CJ
9. Purt B
A Call to Action and Roadmap for Improving Emergency Treatment of Ophthalmic Trauma in the United States.; Ophthalmology. 2025 Aug 25.
1. Roztocil E
2. Husain F
3. Patrick CC
4. Feldon SE
5. Woeller CF
Targeting the Aryl Hydrocarbon Receptor to Attenuate IGF1R Signaling in Thyroid Eye Disease.; Thyroid : official journal of the American Thyroid Association. 2025 Apr 21.
1. Patrick CC
2. Roztocil E
3. Husain F
4. Feldon SE
5. Woeller CF
Tapinarof, an Aryl Hydrocarbon Receptor Ligand, Mitigates Fibroblast Activation in Thyroid Eye Disease: Implications for Novel Therapy.; Investigative ophthalmology & visual science; Vol 65(13), pp. 40. 2024 Nov 04.
1. Dogra N
2. Redmond BV
3. Lilley S
4. Johnson BA
5. Lam BL
6. Tamhankar M
7. Feldon SE
8. Fahrenthold B
9. Yang J
10. Huxlin KR
11. Cavanaugh MR
Vision-related quality of life after unilateral occipital stroke.; Brain and behavior; Vol 14(7), pp. e3582. 2024 Jul.
1. Fahrenthold BK
2. Cavanaugh MR
3. Tamhankar M
4. Lam BL
5. Feldon SE
6. Johnson BA
7. Huxlin KR
Training in Cortically Blinded Fields Appears to Confer Patient-Specific Benefit Against Retinal Thinning.; Investigative ophthalmology & visual science; Vol 65(4), pp. 29. 2024 Apr 01.
1. Fahrenthold BK
2. Cavanaugh MR
3. Tamhankar M
4. Lam BL
5. Feldon SE
6. Johnson BA
7. Huxlin KR
Training in cortically-blind fields confers patient-specific benefit against retinal thinning after occipital stroke.; medRxiv : the preprint server for health sciences. 2023 Dec 20.
1. Kahaly GJ
2. Dolman PJ
3. Wolf J
4. Giers BC
5. Elflein HM
6. Jain AP
7. Srinivasan A
8. Hadjiiski L
9. Jordan D
10. Bradley EA
11. Stan MN
12. Eckstein A
13. Pitz S
14. Vorländer C
15. Wester ST
16. Nguyen J
17. Tucker N
18. Sales-Sanz M
19. Feldon SE
20. Nelson CC
21. Hardy I
22. Abia-Serrano M
23. Tedeschi P
24. Janes JM
25. Xu J
26. Vue P
27. Macias WL
28. Douglas RS
Proof-of-Concept and Randomized, Placebo-Controlled Trials of an Fcrn Inhibitor, Batoclimab, for Thyroid Eye Disease.; The Journal of clinical endocrinology and metabolism. 2023 Jun 30.
1. Valencia WE
2. Mason SS
3. Brunstetter TJ
4. Sargsyan AE
5. Schaefer CM
6. Tarver WJ
7. Van Baalen MG
8. Gibson CR
9. Lee AG
10. Danilichev SN
11. Hinton PV
12. Makarov IA
13. Matveev VP
14. Stern CH
15. Taniguchi-Shinojima A
16. Feldon SE
Evaluation of Optic Disc Edema in Long-Duration Spaceflight Crewmembers Using Retinal Photography.; Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society. 2023 Jan 04.
1. Wang V
2. Heffer A
3. Roztocil E
4. Feldon SE
5. Libby RT
6. Woeller CF
7. Kuriyan AE
TNF-α and NF-κB signaling play a critical role in cigarette smoke-induced epithelial-mesenchymal transition of retinal pigment epithelial cells in proliferative vitreoretinopathy.; PloS one; Vol 17(9), pp. e0271950. 2022 Sep 01.
1. Hammond CL
2. Roztocil E
3. Gupta V
4. Feldon SE
5. Woeller CF
More than Meets the Eye: The Aryl Hydrocarbon Receptor is an Environmental Sensor, Physiological Regulator and a Therapeutic Target in Ocular Disease.; Frontiers in toxicology; Vol 4. 2022.
1. Moss HE
2. Cao J
3. Wasi M
4. Feldon SE
5. Shahidi M
Variability of Retinal Vessel Tortuosity Measurements Using a Semiautomated Method Applied to Fundus Images in Subjects With Papilledema.; Translational vision science & technology; Vol 10(14). 2021 Dec 01.
1. Quillen DA
2. Lee PP
3. Miller JW
4. Feldon SE
Re: Fairless et al.: Ophthalmology departments remain among the least diverse clinical departments at United States medical schools (Ophthalmology. 2021;128:1129-1134).; Ophthalmology. 2021 Nov 06.
1. Gupta V
2. Hammond CL
3. Roztocil E
4. Gonzalez MO
5. Feldon SE
6. Woeller CF
Thinking inside the box: Current insights into targeting orbital tissue remodeling and inflammation in thyroid eye disease.; Survey of ophthalmology. 2021 Sep 03.
1. Hammond CL
2. Roztocil E
3. Gonzalez MO
4. Feldon SE
5. Woeller CF
MicroRNA-130a Is Elevated in Thyroid Eye Disease and Increases Lipid Accumulation in Fibroblasts Through the Suppression of AMPK.; Investigative ophthalmology & visual science; Vol 62(1). 2021 Jan 04.
1. Cavanaugh MR
2. Blanchard LM
3. McDermott M
4. Lam BL
5. Tamhankar M
6. Feldon SE
Efficacy of Visual Retraining in the Hemianopic Field After Stroke: Results of a Randomized Clinical Trial.; Ophthalmology. 2020 Nov 23.
1. Saionz EL
2. Feldon SE
3. Huxlin KR
Rehabilitation of cortically induced visual field loss.; Current opinion in neurology. 2020 Nov 20.
1. Heffer A
2. Wang V
3. Sridhar J
4. Feldon SE
5. Libby RT
6. Woeller CF
7. Kuriyan AE
A Mouse Model of Proliferative Vitreoretinopathy Induced by Intravitreal Injection of Gas and RPE Cells.; Translational vision science & technology; Vol 9(7). 2020 Jun.
1. Roztocil E
2. Hammond CL
3. Gonzalez MO
4. Feldon SE
5. Woeller CF
The aryl hydrocarbon receptor pathway controls matrix metalloproteinase-1 and collagen levels in human orbital fibroblasts.; Scientific reports; Vol 10(1). 2020 May 21.
1. Moss HE
2. Hollar RA
3. Fischer WS
4. Feldon SE
Retinal vessel diameter changes after 6 months of treatment in the Idiopathic Intracranial Hypertension Treatment Trial.; The British journal of ophthalmology. 2020 Jan 16.
1. Heffer AM
2. Wang V
3. Libby RT
4. Feldon SE
5. Woeller CF
6. Kuriyan AE
Salinomycin inhibits proliferative vitreoretinopathy formation in a mouse model.; PloS one; Vol 15(12). 2020.
1. Woeller CF
2. Roztocil E
3. Hammond C
4. Feldon SE
TSHR Signaling Stimulates Proliferation Through PI3K/Akt and Induction of miR-146a and miR-155 in Thyroid Eye Disease Orbital Fibroblasts.; Investigative ophthalmology & visual science; Vol 60(13). 2019 Oct 01.
1. Heffer AM
2. Proaño J
3. Roztocil E
4. Phipps RP
5. Feldon SE
6. Huxlin KR
7. Sime PJ
8. Libby RT
9. Woeller CF
10. Kuriyan AE
The polyether ionophore salinomycin targets multiple cellular pathways to block proliferative vitreoretinopathy pathology.; PloS one; Vol 14(9). 2019.
1. Hammond CL
2. Roztocil E
3. Phipps RP
4. Feldon SE
5. Woeller CF
Proton pump inhibitors attenuate myofibroblast formation associated with thyroid eye disease through the aryl hydrocarbon receptor.; PloS one; Vol 14(9). 2019.
1. Sheils CR
2. Fischer WS
3. Hollar RA
4. Blanchard LM
5. Feldon SE
The Relationship Between Optic Disc Volume, Area, and Frisén Score in Patients With Idiopathic Intracranial Hypertension.; American journal of ophthalmology; Vol 195. 2018 Jan.
1. Ramchandran RS
2. Feldon SE
3. Owsley C
Current Shortcomings of Camera Screening.; JAMA internal medicine; Vol 177(10). 2017 Oct 01.
1. Kupersmith MJ
2. Sibony PA
3. Feldon SE
4. Wang JK
5. Garvin M
6. Kardon R
The Effect of Treatment of Idiopathic Intracranial Hypertension on Prevalence of Retinal and Choroidal Folds.; American journal of ophthalmology; Vol 176. 2017 Apr.
1. Woeller CF
2. Roztocil E
3. Hammond CL
4. Feldon SE
5. Phipps RP
The Aryl Hydrocarbon Receptor and Its Ligands Inhibit Myofibroblast Formation and Activation: Implications for Thyroid Eye Disease.; The American journal of pathology; Vol 186(12). 2016 Dec.
1. Bingham CM
2. Sivak-Callcott JA
3. Gurka MJ
4. Nguyen J
5. Hogg JP
6. Feldon SE
7. Fay A
8. Seah LL
9. Strianese D
10. Durairaj VD
11. Uddin J
12. Devoto MH
13. Harris M
14. Saunders J
15. Osaki TH
16. Looi A
17. Teo L
18. Davies BW
19. Elefante A
20. Shen S
21. Realini T
22. Fischer W
23. Kazim M
Axial Globe Position Measurement: A Prospective Multicenter Study by the International Thyroid Eye Disease Society.; Ophthalmic plastic and reconstructive surgery; Vol 32(2). 2016 Mar.
1. Sibony PA
2. Kupersmith MJ
3. Feldon SE
4. Kardon R
Author Response: Choroidal Folds in Astronauts.; Investigative ophthalmology & visual science; Vol 57(2). 2016 Feb.
1. Sibony PA
2. Kupersmith MJ
3. Feldon SE
4. Wang JK
5. Garvin M
Retinal and Choroidal Folds in Papilledema.; Investigative ophthalmology & visual science; Vol 56(10). 2015 Sep.
1. Fischer WS
2. Wall M
3. McDermott MP
4. Kupersmith MJ
5. Feldon SE
Photographic Reading Center of the Idiopathic Intracranial Hypertension Treatment Trial (IIHTT): Methods and Baseline Results.; Investigative ophthalmology & visual science; Vol 56(5). 2015 May.
1. Woeller CF
2. O'Loughlin CW
3. Pollock SJ
4. Thatcher TH
5. Feldon SE
6. Phipps RP
Thy1 (CD90) controls adipogenesis by regulating activity of the Src family kinase, Fyn.; FASEB journal : official publication of the Federation of American Societies for Experimental Biology; Vol 29(3). 2015 Mar.
1. Woeller CF
2. O'Loughlin CW
3. Roztocil E
4. Feldon SE
5. Phipps RP
Salinomycin and other polyether ionophores are a new class of antiscarring agent.; The Journal of biological chemistry; Vol 290(6). 2015 Feb 6.
1. Spinelli SL
2. Xi X
3. McMillan DH
4. Woeller CF
5. Richardson ME
6. Cavet ME
7. Zhang JZ
8. Feldon SE
9. Phipps RP
Mapracorat, a selective glucocorticoid receptor agonist, upregulates RelB, an anti-inflammatory nuclear factor-kappaB protein, in human ocular cells.; Experimental eye research; Vol 127. 2014 Oct.
1. Friedman DI
2. McDermott MP
3. Kieburtz K
4. Kupersmith M
5. Stoutenburg A
6. Keltner JL
7. Feldon SE
8. Schron E
9. Corbett JJ
10. Wall M
The idiopathic intracranial hypertension treatment trial: design considerations and methods.; Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society; Vol 34(2). 2014 Jun.
1. Wall M
2. Kupersmith MJ
3. Kieburtz KD
4. Corbett JJ
5. Feldon SE
6. Friedman DI
7. Katz DM
8. Keltner JL
9. Schron EB
10. McDermott MP
The idiopathic intracranial hypertension treatment trial: clinical profile at baseline.; JAMA neurology; Vol 71(6). 2014 Jun.
1. Wall M
2. McDermott MP
3. Kieburtz KD
4. Corbett JJ
5. Feldon SE
6. Friedman DI
7. Katz DM
8. Keltner JL
9. Schron EB
10. Kupersmith MJ
Effect of acetazolamide on visual function in patients with idiopathic intracranial hypertension and mild visual loss: the idiopathic intracranial hypertension treatment trial.; JAMA; Vol 311(16). 2014 Feb.
1. Kuriyan AE
2. Woeller CF
3. O'Loughlin CW
4. Phipps RP
5. Feldon SE
Orbital fibroblasts from thyroid eye disease patients differ in proliferative and adipogenic responses depending on disease subtype.; Investigative ophthalmology & visual science; Vol 54(12). 2013 Nov.
1. Miller B
2. Khalifa Y
3. Feldon SE
4. Friedman DI
Lemierre syndrome causing bilateral cavernous sinus thrombosis.; Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society; Vol 32(4). 2012 Dec.
1. Kuriyan AE
2. Lehmann GM
3. Kulkarni AA
4. Woeller CF
5. Feldon SE
6. Hindman HB
7. Sime PJ
8. Huxlin KR
9. Phipps RP
Electrophilic PPARγ ligands inhibit corneal fibroblast to myofibroblast differentiation in vitro: a potentially novel therapy for corneal scarring.; Experimental eye research; Vol 94(1). 2012 Jan.
1. Abazari A
2. Chak G
3. Feldon SE
Reply re: "Sinus opacification associated with exacerbation of thyroid eye disease".; Ophthalmic plastic and reconstructive surgery; Vol 27(4). 2011 Jul.
1. Chak G
2. Wang HZ
3. Feldon SE
Coup de sabre presenting with worsening diplopia and enophthalmos.; Ophthalmic plastic and reconstructive surgery; Vol 27(4). 2011 Jul.
1. Xi X
2. McMillan DH
3. Lehmann GM
4. Sime PJ
5. Libby RT
6. Huxlin KR
7. Feldon SE
8. Phipps RP
Ocular fibroblast diversity: implications for inflammation and ocular wound healing.; Investigative ophthalmology & visual science; Vol 52(7). 2011 Jun.
1. Guo N
2. Woeller CF
3. Feldon SE
4. Phipps RP
Peroxisome proliferator-activated receptor gamma ligands inhibit transforming growth factor-beta-induced, hyaluronan-dependent, T cell adhesion to orbital fibroblasts.; The Journal of biological chemistry; Vol 286(21). 2011 May 27.
1. Lehmann GM
2. Xi X
3. Kulkarni AA
4. Olsen KC
5. Pollock SJ
6. Baglole CJ
7. Gupta S
8. Casey AE
9. Huxlin KR
10. Sime PJ
11. Feldon SE
12. Phipps RP
The aryl hydrocarbon receptor ligand ITE inhibits TGFβ1-induced human myofibroblast differentiation.; The American journal of pathology; Vol 178(4). 2011 Apr.
1. Lehmann GM
2. Woeller CF
3. Pollock SJ
4. O'Loughlin CW
5. Gupta S
6. Feldon SE
7. Phipps RP
Novel anti-adipogenic activity produced by human fibroblasts.; American journal of physiology. Cell physiology; Vol 299(3). 2010 Sep.
1. Abazari A
2. Chak G
3. Feldon SE
Sinus opacification associated with exacerbation of thyroid eye disease.; Ophthalmic plastic and reconstructive surgery; Vol 26(4). 2010 Jul.
1. Guo N
2. Baglole CJ
3. O'Loughlin CW
4. Feldon SE
5. Phipps RP
Mast cell-derived prostaglandin D2 controls hyaluronan synthesis in human orbital fibroblasts via DP1 activation: implications for thyroid eye disease.; The Journal of biological chemistry; Vol 285(21). 2010 May 21.
1. Simpson-Haidaris PJ
2. Pollock SJ
3. Ramon S
4. Guo N
5. Woeller CF
6. Feldon SE
7. Phipps RP
Anticancer Role of PPARgamma Agonists in Hematological Malignancies Found in the Vasculature, Marrow, and Eyes.; PPAR research; Vol 2010. 2010.
1. Perry JD
2. Feldon SE
Rationale for radiotherapy in thyroid eye disease.; American journal of ophthalmology; Vol 148(6). 2009 Dec.
1. Williams ZR
2. Hurley PE
3. Altiparmak UE
4. Feldon SE
5. Arnold GL
6. Eggenberger E
7. Mejico LJ
Late onset optic neuropathy in methylmalonic and propionic acidemia.; American journal of ophthalmology; Vol 147(5). 2009 May.
1. Stasi K
2. Ramchandran RS
3. Rao NA
4. Feldon SE
5. DiLoreto DA
Retinal arteriolar spasm during transient monocular visual loss in eosinophilic vasculitis.; Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society; Vol 29(1). 2009 Mar.
1. Kuriyan AE
2. Phipps RP
3. Feldon SE
The eye and thyroid disease.; Current opinion in ophthalmology; Vol 19(6). 2008 Nov.
1. Feldon SE
Optic neuritis and the risk of multiple sclerosis--what can we learn from a brain MRI scan?; Nature clinical practice. Neurology; Vol 4(10). 2008 Oct.
1. Scherer RW
2. Feldon SE
3. Levin L
4. Langenberg P
5. Katz J
6. Keyl PM
7. Wilson PD
8. Kelman SE
9. Dickersin K
Visual fields at follow-up in the Ischemic Optic Neuropathy Decompression Trial: evaluation of change in pattern defect and severity over time.; Ophthalmology; Vol 115(10). 2008 Oct.
1. Lehmann GM
2. Feldon SE
3. Smith TJ
4. Phipps RP
Immune mechanisms in thyroid eye disease.; Thyroid : official journal of the American Thyroid Association; Vol 18(9). 2008 Sep.
1. Kuriyan AE
2. Phipps RP
3. O'Loughlin CW
4. Feldon SE
Improvement of thyroid eye disease following treatment with the cyclooxygenase-2 selective inhibitor celecoxib.; Thyroid : official journal of the American Thyroid Association; Vol 18(8). 2008 Aug.
1. Lehmann GM
2. Garcia-Bates TM
3. Smith TJ
4. Feldon SE
5. Phipps RP
Regulation of Lymphocyte Function by PPARgamma: Relevance to Thyroid Eye Disease-Related Inflammation.; PPAR research; Vol 2008. 2008.
1. Cruz OA
2. Roper-Hall G
3. Feldon SE
Relaxed muscle positioning technique.; Ophthalmology; Vol 114(11). 2007 Nov.
1. Zoumalan CI
2. Cockerham KP
3. Turbin RE
4. Volpe NJ
5. Kazim M
6. Douglas RS
7. Feldon SE
Efficacy of corticosteroids and external beam radiation in the management of moderate to severe thyroid eye disease.; Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society; Vol 27(3). 2007 Sep.
1. Feldon SE
Visual outcomes comparing surgical techniques for management of severe idiopathic intracranial hypertension.; Neurosurgical focus; Vol 23(5). 2007.
1. Feldon SE
2. O'loughlin CW
3. Ray DM
4. Landskroner-Eiger S
5. Seweryniak KE
6. Phipps RP
Activated human T lymphocytes express cyclooxygenase-2 and produce proadipogenic prostaglandins that drive human orbital fibroblast differentiation to adipocytes.; The American journal of pathology; Vol 169(4). 2006 Oct.
1. Baglole CJ
2. Ray DM
3. Bernstein SH
4. Feldon SE
5. Smith TJ
6. Sime PJ
7. Phipps RP
More than structural cells, fibroblasts create and orchestrate the tumor microenvironment.; Immunological investigations; Vol 35(3-4). 2006.
1. Feldon SE
2. Levin L
3. Scherer RW
4. Arnold A
5. Chung SM
6. Johnson LN
7. Kosmorsky G
8. Newman SA
9. Katz J
10. Langenberg P
11. Wilson PD
12. Kelman SE
13. Dickersin K
Development and validation of a computerized expert system for evaluation of automated visual fields from the Ischemic Optic Neuropathy Decompression Trial.; BMC ophthalmology; Vol 6. 2006.
1. Feldon S
2. Levin L
3. Scherer R
4. Arnold A
5. Chung SM
6. Johnson L
7. Kosmorsky G
8. Newman S
9. Katz J
10. Langenberg P
11. Wilson PD
12. Kelman SE
13. Kickersin K
Development and Validation of a Computerized Expert System for Evaluation of Automated Visual Feilds From the Ischemic Optic Neuopathy Decompression Trial.; Biomedical Central Ophthalmology. 2006 Jan 01.
1. Feldon SE
2. Park DJ
3. O'Loughlin CW
4. Nguyen VT
5. Landskroner-Eiger S
6. Chang D
7. Thatcher TH
8. Phipps RP
Autologous T-lymphocytes stimulate proliferation of orbital fibroblasts derived from patients with Graves' ophthalmopathy.; Investigative ophthalmology & visual science; Vol 46(11). 2005 Nov.
1. Feldon S
2. Park DJ
3. O'Loughlin CW
4. Nguyen VT
5. Landskroner-Eiger S
6. Chang D
7. Thatcher TH
8. Phipps RP
Autologous T-lymphocytes stimulate proliferation of orbital fibroblasts derived from patients with Graves' ophthalmopathy; IOVS; Vol 46, pp. 3913-21. 2005 Jan 01.
1. Baglole CJ
2. Reddy SY
3. Pollock SJ
4. Feldon SE
5. Sime PJ
6. Smith TJ
7. Phipps RP
Isolation and phenotypic characterization of lung fibroblasts.; Methods in molecular medicine; Vol 117. 2005.
1. Turner CK
2. Blieden TM
3. Smith TJ
4. Feldon SE
5. Foster DC
6. Sime PJ
7. Phipps RP
A novel ELISpot method for adherent cells.; Journal of immunological methods; Vol 291(1-2). 2004 Aug.
1. Kim JM
2. LaBree L
3. Levin L
4. Feldon SE
The relation of Graves' ophthalmopathy to circulating thyroid hormone status.; The British journal of ophthalmology; Vol 88(1). 2004 Jan.
1. Feldon SE
Computerized expert system for evaluation of automated visual fields from the Ischemic Optic Neuropathy Decompression Trial: methods, baseline fields, and six-month longitudinal follow-up.; Transactions of the American Ophthalmological Society; Vol 102. 2004.
1. Koumas L
2. Smith TJ
3. Feldon S
4. Blumberg N
5. Phipps RP
Thy-1 expression in human fibroblast subsets defines myofibroblastic or lipofibroblastic phenotypes.; The American journal of pathology; Vol 163(4). 2003 Oct.
1. Schmitt NJ
2. Grover DA
3. Feldon SE
The Eger Macular Stressometer: pilot study.; American journal of ophthalmology; Vol 136(2). 2003 Aug.
1. Feldon SE
2. Scherer RW
3. Hooper FJ
4. Kelman S
5. Baker RS
6. Granadier RJ
7. Kosmorsky GS
8. Seiff SR
9. Dickersin K
Surgical quality assurance in the Ischemic Optic Neuropathy Decompression Trial (IONDT).; Controlled clinical trials; Vol 24(3). 2003 Jun.
1. Scherer R
2. Zhu Q
3. Langenberg P
4. Feldon S
5. Kelman S
6. Dickersin K
Comparison of information obtained by operative note abstraction with that recorded on a standardized data collection form.; Surgery; Vol 133(3). 2003 Mar.
1. Crow RW
2. Levin LB
3. LaBree L
4. Rubin R
5. Feldon SE
Sweep visual evoked potential evaluation of contrast sensitivity in Alzheimer's dementia.; Investigative ophthalmology & visual science; Vol 44(2). 2003 Feb.
1. Quiros P
2. Feldon SF
Update on Nonarteritic Anterior Ischemic Optic Neuropathy.; Comprehensive Ophthalmology; Vol 4, pp. 151-158. 2003 Jan 01.
1. Nguyen VT
2. Park DJ
3. Levin L
4. Feldon SE
Correction of restricted extraocular muscle motility in surgical management of strabismus in graves' ophthalmopathy.; Ophthalmology; Vol 109(2). 2002 Feb.
1. JJ N
2. Scherer R
3. Langenberg P
4. Kelman S
5. Feldon S
6. Kaufman D
7. Dickersin K
The fellow eye in NAION: Report from the Ischemic Optic Neuropathy Decompression Trial.; Am J of Ophthalmology; Vol 134, pp. 317-28. 2002 Jan 01.
1. Feldon SE
Radiation therapy for Graves' ophthalmopathy: trick or treat?; Ophthalmology; Vol 108(9). 2001 Sep.
1. Lee AG
2. Tang RA
3. Feldon SE
4. Pless M
5. Schiffman JS
6. Rubin RM
7. Rao N
Orbital presentations of giant cell arteritis.; Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv für klinische und experimentelle Ophthalmologie; Vol 239(7). 2001 Jul.
1. Liu NH
2. LaBree LD
3. Feldon SE
4. Rao NA
The epidemiology of giant cell arteritis : a 12-year retrospective study.; Ophthalmology; Vol 108(6). 2001 Jun.
1. Bhagat N
2. Green RL
3. Feldon SE
4. Lim JI
Exudative retinal detachment in relapsing polychondritis : case report and literature review.; Ophthalmology; Vol 108(6). 2001 Jun.
1. Bhagat N
2. Green RL
3. Feldon SE
4. Lim JI
Exudative Retinal Detachment in Relapsing Polychondritis: case report and literature review.; Ophthalmol; Vol 108, pp. 1156-9. 2001 Jan 01.
1. Feldon SE
Radiation therapy for Graves' ophthalmopathy: trick or treat?; Ophthalmol; Vol 108, pp. 1521-2. 2001 Jan 01.
Ischemic Optic Neuropathy Decompression Trial: twenty-four-month update.; Archives of ophthalmology (Chicago, Ill. : 1960); Vol 118(6). 2000 Jun.
1. Chou PI
2. Chen CH
3. Chen JT
4. Wen LY
5. Wu DA
6. Feldon SE
Alström syndrome with subclinical insulin-resistant diabetes and hepatic dysfunction: a family report.; Journal of pediatric ophthalmology and strabismus; Vol 37(3). 2000 May.
1. Prendiville P
2. Chopra M
3. Gauderman WJ
4. Feldon SE
The role of restricted motility in determining outcomes for vertical strabismus surgery in Graves' ophthalmology.; Ophthalmology; Vol 107(3). 2000 Mar.
1. Prendiville P
2. Chopra M
3. Gauderman WJ
4. Feldon SE
The Role of Restricted Motility in Determining Outcomes for Vertical Strabismus Surgery in Graves' Ophthalmopathy.; Ophthalmolol; Vol 107, pp. 545-549. 2000 Jan 01.
1. Chou PI
2. Chang YS
3. Feldon SE
4. Chen JT
Optic canal mucocele from anterior clinoid pneumatisation.; The British journal of ophthalmology; Vol 83(11). 1999 Nov.
1. Wang MY
2. Sadun F
3. Levin LB
4. LaBree L
5. Feldon SE
Occurrence of familial nonarteritic anterior ischemic optic neuropathy in a case series.; Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society; Vol 19(2). 1999 Jun.
1. Feldon SE
Anterior ischemic optic neuropathy: trouble waiting to happen.; Ophthalmology; Vol 106(4). 1999 Apr.
1. Wang MY
2. Sadun F
3. Levin LB
4. LaBree L
5. Feldon SE
Occurrence and clinical profile of familial non-arteritic optic neuropathy.; J Neuro-Ophthalmol; Vol 19, pp. 144-147. 1999 Jan 01.
1. Liu NH
2. LaBree LD
3. Feldon SE
4. Rao NA
The Epidemiology of Giant Cell Arteritis.; Opthalmol; Vol 106, pp. 651-652. 1999 Jan 01.
The ischemic optic neuropathy decompression trial (IONDT): design and methods.; Controlled clinical trials; Vol 19(3). 1998 Jun.
1. Tran DB
2. Silverman SE
3. Zimmerman K
4. Feldon SE
Age-related deterioration of motion perception and detection.; Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie; Vol 236(4). 1998 Apr.
1. Tran DB
2. Silverman SE
3. Zimmerman KM
4. Feldon SE
Age-related deterioration of motion perception and detection.; Graefe's Arch Clin Exp Ophthalmol; Vol 236, pp. 269-273. 1998 Jan 01.
1. Crawley B
2. Scherer R
3. Langenberg P
4. Dickersin K
Participation in the Ischemic Optic Neuropathy Decompression Trial: sex, race, and age.; Ophthalmic epidemiology; Vol 4(3). 1997 Sep.